An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

Background: The approval process of every drug regulatory agency differs, and hence, the time required for the approval of a new drug varies. This results in a drug lag and India is no exception to this phenomenon. A drug lag precludes Indian patients from accessing new medicines at the same time as...

Full description

Bibliographic Details
Main Authors: Mahanjit Konwar, Mitesh R Maurya, Tushar B Nishandar, Urmila M Thatte, Nithya J Gogtay
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Perspectives in Clinical Research
Subjects:
absolute drug lag
central drugs standard control organization
european medicines agency
pharmaceuticals and medical devices agency
relative drug lag
united states food and drug administration
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2021;volume=12;issue=3;spage=159;epage=164;aulast=

Internet

http://www.picronline.org/article.asp?issn=2229-3485;year=2021;volume=12;issue=3;spage=159;epage=164;aulast=

Similar Items